Precision Business Insights published a research report on “Respiratory Inhaler Devices Market: By Product Type (Metered Dose Inhaler, Nebulizer, Dry Powder Inhaler), By Technology (Manually Operated Inhalers, Digitally Operated Inhalers), By Disease Indication (Asthma, Chronic Obstructive Pulmonary Disease (COPD), Pulmonary Arterial Hypertension, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Geography– Global/Region/Country Forecast to 2027″, Respiratory Inhaler Devices Market was valued at USD 3.04 Billion in 2020 and is anticipated to grow at USD 49.84 Billion till 2027 recording a CAGR of 7% during the forecast period 2021-2027.
Glance our 200 slides market research and competitive intelligence research report, 25 Tables and 65 Figures and other qualitative sections with an in-depth TOC on ” Respiratory Inhaler Devices Market: By Product Type (Metered Dose Inhaler, Nebulizer, Dry Powder Inhaler), By Technology (Manually Operated Inhalers, Digitally Operated Inhalers), By Disease Indication (Asthma, Chronic Obstructive Pulmonary Disease (COPD), Pulmonary Arterial Hypertension, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Geography– Global/Region/Country Forecast to 2027″,
View detailed Report Description @ https://precisionbusinessinsights.com/market-reports/global-respiratory-inhaler-devices-market/
Respiratory inhaler devices are used to give medication to the patient for preventing asthma, chronic obstructive pulmonary illnesses and other respiratory disorders. These devices are medical devices and available in different types in the market such as nebulizer, metered dose inhaler and dry powder inhaler. There are numerous significant factors that are projected to drive the respiratory inhaler devices market during the evaluation period 2021-2027 such as growing aged and newborn babies population who frequently suffer from respiratory disorders, ease of drug administration using respiratory inhaler devices and cost effective of the products. Technological developments in respiratory inhaler devices, increasing smoking population and fast industrialization are some important factors evaluated to foster the market. But, dearth of awareness in underdeveloped countries about respiratory inhalers, severe effects involved with drug inhalation, lack of single inhalers to treat all kinds of illnesses and products recalls projected to hinder the market growth during the forecast years.
In addition, industry players in the market are concentrating more on developing novel respiratory inhaler devices to ease drug administration process. These players are following a few effective strategies such as new product launchings, acquisitions, product approvals and mergers to gain huge revenue share in respiratory inhaler devices market. For instance, AstraZeneca got FDA approval for Bevepsi Aeresphere inhalation aerosol used for treating chronic obstructive pulmonary illnesses (COPD). Novartis AG collaborated with Qualcomm, Inc. in January 2016 to bring digital technology for Breezhaler inhaler utilized to treat COPD.
Impact of COVID-19 on Respiratory Inhaler Devices Market:
In addition, the report discusses the implications of COVID-19, including the industry’s initial response and strategies for ensuring business continuity in the coming years.
Request a case study or sample research report @ https://precisionbusinessinsights.com/request-sample?product_id=18994
Respiratory Inhaler Devices Market – Regional Analysis
On the basis of regional analysis, global respiratory inhaler devices market is divided into major regions such as North America, Asia Pacific, Middle East, Africa Europe and Latin America. North America market is growing owing to huge awareness about the respiratory inhalers and growth in occurrence of respiratory disorders like COPD. Respiratory inhaler devices market is driven in Europe by the growing adoption of novel respiratory inhaler devices, increasing asthma cases mainly in countries like Switzerland, Sweden, and Belgium, Portugal and Austria and focus of market players on the business expansion in the region.
Competitive Analysis
A few of the major players of the global respiratory inhaler devices market are Cipla Ltd. (India), Beximco Pharmaceuticals Ltd. (Bangladesh), Merck & Co., Inc. (U.S.), GlaxoSmithKline plc (U.K.), AstraZeneca plc (U.K.), Boehringer Ingelheim GmbH (Germany), Teva Pharmaceutical Industries Ltd. (Israel), OMRON Healthcare Europe B.V. (Netherlands) and Novartis AG (Switzerland).
About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.
Precision Business Insights offers a variety of cost-effective and customized research services to meet particular research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.
Contact:
Mr. Satya
Precision Business InsightsTM | Toll Free: +1 866 598 1553
Email: [email protected]
Kemp House, 152 – 160 City Road, London EC1V 2NX
Web: https://precisionbusinessinsights.com/ | D U N S® Number: 852781747
